Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Sep;101(9):1185-1192.
doi: 10.1136/bjophthalmol-2016-309729. Epub 2017 Jan 20.

Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report

Affiliations
Comparative Study

Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report

Nichole Joachim et al. Br J Ophthalmol. 2017 Sep.

Abstract

Purpose: To assess the 5-year progression from unilateral to bilateral age-related macular degeneration (AMD) and associated risk factors.

Design: Pooled data analyses of three prospective population-based cohorts, the Blue Mountains Eye Study, Beaver Dam Eye Study and Rotterdam Study.

Methods: Retinal photography and interview with comprehensive questionnaires were conducted at each visit of three studies. AMD was assessed following the modified Wisconsin AMD grading protocol. Progression to bilateral any (early and late) or late AMD was assessed among participants with unilateral involvement only. Factors associated with the progression were assessed using logistic regression models while simultaneously adjusting for other significant risk factors.

Results: In any 5-year duration, 19-28% of unilateral any AMD cases became bilateral and 27-68% of unilateral late AMD became bilateral. Factors associated with the progression to bilateral involvement of any AMD were age (per year increase, adjusted OR 1.07), carrying risk alleles of the complement factor H and age-related maculopathy susceptibility 2 genes (compared with none, OR 1.76 for 1 risk allele and OR 3.34 for 2+ risk alleles), smoking (compared with non-smokers, OR 1.64 for past and OR 1.67 for current smokers), and the presence of large drusen area or retinal pigmentary abnormalities in the first eye.

Conclusion: One in four to one in five unilateral any AMD cases, and up to one in two unilateral late AMD cases, progressed to bilateral in 5 years. Known AMD risk factors, including smoking, are significantly associated with the progression to bilateral involvement.

Keywords: Degeneration; Epidemiology; Macula.

PubMed Disclaimer

Conflict of interest statement

Competing interests: There are no financial disclosures for all authors except for PM and CCWK, who have provided consultancy to Bayer (PM, CCWK), Novartis (PM, CCWK) and Allergan (PM) and received payment and travel/accommodations from these companies for lectures.

Figures

Figure 1
Figure 1
ROC curve indicating the prognostic performance of the model in predicting probabilities of 5-year progression from unilateral to bilateral involvement by any age-related macular degeneration. A ROC curve that follows the left-hand and top axes of the graph (AUC=1) indicates that the model provides perfect discrimination, whereas a diagonal line from the bottom left-hand corner of the graph to the top right-hand corner (AUC=0.5) indicates a model with no discriminative value. Sensitivity (the true positive rate) indicates the proportion of participants with progression who were correctly identified by the model, whereas 1−specificity (the false positive rate) indicates the proportion of participants without progression who were misidentified by the model. AUC, area under the ROC curve; ROC, receiver operating characteristic.

References

    1. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–51. - PMC - PubMed
    1. Sengupta S, Nguyen AM, van Landingham SW, et al. Evaluation of real-world mobility in age-related macular degeneration. BMC Ophthalmol. 2015;15:9. - PMC - PubMed
    1. Cahill MT, Banks AD, Stinnett SS, et al. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112:152–8. - PubMed
    1. Mitchell P, Wang JJ, Foran S, et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109:1092–7. - PubMed
    1. Wang JJ, Rochtchina E, Lee AJ, et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology. 2007;114:92–8. - PubMed

MeSH terms